I honestly believe, whatever transpired, that PAA is on the fastest possible track to get MPL into the hands of MND sufferers.
When you strip everything else away, does anything else really matter?
IMO, focus the conversation on constructive ways MPL can benefit neurodegenerative patients and improve the overall knowledge base, thereby adding value to the entire ecosystem, including shareholders.
I honestly believe, whatever transpired, that PAA is on the...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $89.95M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.5¢ | $47.2K | 254.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18267 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 498743 | 8 |
View Market Depth
| Last trade - 10.32am 02/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |